Szyguła-Jurkiewicz Bozena, Wojnicz Romuald, Trzeciak Przemysław, Niklewski Tomasz, Zembala Marian, Poloński Lech
III Katedra i Oddział Kliniczny Kardiologii, Slaskiej Akademii Medycznej, Kierownik Kliniki.
Przegl Lek. 2005;62(5):265-9.
Early invasive strategy is one of alternative methods for management of acute coronary syndromes (ACS) without persistent ST-segment elevation.
The aim of the study was analysis of clinical characteristics, in-hospital outcome and factors of in-hospital mortality.
The study group comprised 853 patients who were defined as high-risk, based on resting pain episodes within previous 24 hours, changes of ST-T segment in ECG, and elevated serum cardiac markers. All patients underwent coronary angiography followed by PCI (percutaneous coronary interventions) in 73.1% of patients. 16.7% were assigned to CABG (coronary artery bypass graft), 1.6% of patients underwent PCI and CABG and 8.6% of patients were treated conservatively.
Overall in-hospital mortality was 3%; 1.4% in the PCI group, 8.4% in the CABG group and 6.8% in conservatively treated patients. The independent risk factors of in-hospital deaths were: Braunwald's IIIC class angina (OR 7.8; 95%CI 3.6-12.37 p=0.004), recurrent angina after revascularization (OR 13.04; 95%CI 7.62-29.23 p=0.002), congestive heart failure (OR 11.45; 95%CI 8.01-18,38 p=0.00001) and evolving myocardial infarction with ST-segment elevation (OR 12.77; 95%CI 8.35-27.35 p=0.0001). Stent implantation was associated with decreased risk of in-hospital death (OR 0.12; 95%CI 0.07-0.41; p=0.003).
Early invasive strategy in patients with ACS without ST-segment elevation is efficacious method of treatment. Independent predictors of in-hospital deaths are: Braunwald's IIIC class angina, congestive heart failure, recurrent angina after revascularization, myocardial infarction complicating hospital course. Stent implantation improves in-hospital prognosis.
早期侵入性策略是治疗无持续性ST段抬高的急性冠状动脉综合征(ACS)的替代方法之一。
本研究的目的是分析临床特征、住院结局及住院死亡率的相关因素。
研究组包括853例患者,这些患者基于前24小时内的静息性疼痛发作、心电图ST-T段变化及血清心脏标志物升高被定义为高危患者。所有患者均接受了冠状动脉造影,其中73.1%的患者随后接受了经皮冠状动脉介入治疗(PCI)。16.7%的患者接受冠状动脉旁路移植术(CABG),1.6%的患者同时接受了PCI和CABG,8.6%的患者接受了保守治疗。
总体住院死亡率为3%;PCI组为1.4%,CABG组为8.4%,保守治疗患者为6.8%。住院死亡的独立危险因素为:Braunwald III C级心绞痛(比值比7.8;95%置信区间3.6 - 12.37,p = 0.004)、血运重建术后复发性心绞痛(比值比13.04;95%置信区间7.62 - 29.23,p = 0.002)、充血性心力衰竭(比值比11.45;95%置信区间8.01 - 18.38,p = 0.00001)及伴有ST段抬高的进展性心肌梗死(比值比12.77;95%置信区间8.35 - 27.35,p = 0.0001)。支架植入与住院死亡风险降低相关(比值比0.12;95%置信区间0.07 - 0.41;p = 0.003)。
对于无ST段抬高的ACS患者,早期侵入性策略是一种有效的治疗方法。住院死亡的独立预测因素为:Braunwald III C级心绞痛、充血性心力衰竭、血运重建术后复发性心绞痛、并发于住院过程中的心肌梗死。支架植入可改善住院预后。